Post-earnings recap
Reported
Wed, Apr 25, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
BioMarin's earnings report showed a significant EPS miss, which typically raises concerns among investors. However, the stock reacted positively, increasing by 0.49%. This could indicate that investors are optimistic about the company's future projects and pipeline, despite the current financial shortfall.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.26 | N/A | -325.46% |
| Revenue | N/A | N/A | N/A |
Management acknowledged the challenges faced this quarter. They emphasized their commitment to advancing their product pipeline despite the EPS miss.
Management did not provide specific guidance for the upcoming quarters.
The company is focused on its ongoing projects and pipeline developments.